Feedback (FDBK)

Sector:

Health Care

Index:

FTSE AIM All-Share

 20.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 140.00
  • 52 Week Low: 19.50
  • Currency: UK Pounds
  • Shares Issued: 13.33m
  • Volume: 0
  • Market Cap: £2.73m
  • RiskGrade: 267
  • Beta: 0.43

Feedback H1 revenues seen 200% higher YOY

By Iain Gilbert

Date: Monday 19 Dec 2022

LONDON (ShareCast) - (Sharecast News) - Medical technology company Feedback said on Monday that revenues had risen roughly 200% in the six months ended 30 November as the group traded in line with internal and external expectations throughout the half.
Feedback said revenues had been positively impacted by the 12-month extension of the firm's pilot programme to provide its Community Diagnostic Centre solution in Sussex, with the £500,000 contract being heralded as an "important milestone" for the company.

The AIM-listed group stated revenue for the period was expected to be roughly £600,000, up from £200,000 a year earlier, while cash and equivalents as at 30 November were pegged to be reported as £9.2m - up from £11.4m twelve months prior.

Looking forward, Feedback said the company will continue to discuss contracts with multiple potential partners across NHS Trusts and CDCs in addition to working on pilot programmes in India.

"These opportunities provide the potential for significant upside with a growing number of routes to markets and end customers underpinning the board's confidence in continued strong growth for the remainder of the financial year," said Feedback.

As of 0920 GMT, Feedback shares were up 1.73% at 86.98p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Feedback Market Data

Currency UK Pounds
Share Price 20.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 140.00
52 Week Low 19.50
Volume 0
Shares Issued 13.33m
Market Cap £2.73m
Beta 0.43
RiskGrade 267

Feedback Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.85% above the market average22.85% above the market average22.85% above the market average22.85% above the market average22.85% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
Price Trend
91.93% below the market average91.93% below the market average91.93% below the market average91.93% below the market average91.93% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
45.59% above the market average45.59% above the market average45.59% above the market average45.59% above the market average45.59% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel

Top of Page